Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medicine Man Technologies ( (SHWZ) ) has provided an announcement.
On July 14, 2025, Medicine Man Technologies appointed Philippe Faraut as the Interim Chief Financial Officer. Mr. Faraut, with over 25 years of experience in finance and investment banking, will serve in this role until January 14, 2026, unless terminated earlier. This strategic appointment is expected to strengthen the company’s financial leadership and operational finance capabilities.
The most recent analyst rating on (SHWZ) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Medicine Man Technologies stock, see the SHWZ Stock Forecast page.
Spark’s Take on SHWZ Stock
According to Spark, TipRanks’ AI Analyst, SHWZ is a Neutral.
Medicine Man Technologies faces considerable financial and operational risks, with weak profitability and high leverage. Technical indicators suggest bearish momentum, and valuation metrics highlight a lack of attractiveness. Corporate events add further uncertainty. The new leadership might bring positive change, but significant challenges need addressing.
To see Spark’s full report on SHWZ stock, click here.
More about Medicine Man Technologies
Average Trading Volume: 11,702
Technical Sentiment Signal: Sell
Current Market Cap: $1.56M
Find detailed analytics on SHWZ stock on TipRanks’ Stock Analysis page.